Impact of drug knowledge on drug errors in an outpatient population of lung transplant recipients

P. Seba, S. Irani, C. Schmid-Mahler, T. Kurowski, R. Speich, A. Boehler (Zurich, Switzerland)

Source: Annual Congress 2007 - Complications and success in lung transplantation
Session: Complications and success in lung transplantation
Session type: Thematic Poster Session
Number: 1102

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Seba, S. Irani, C. Schmid-Mahler, T. Kurowski, R. Speich, A. Boehler (Zurich, Switzerland). Impact of drug knowledge on drug errors in an outpatient population of lung transplant recipients. Eur Respir J 2007; 30: Suppl. 51, 1102

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Microbiological impact of regular colistin use in a population of lung transplant recipients
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012

Prevalence and outcomes of diabetes in lung transplant recipients: the portuguese experience
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020


Improving lung transplant outcomes in France: the high emergency lung transplantation programme
Source: Eur Respir J, 59 (1) 2102209; 10.1183/13993003.02209-2021
Year: 2022



Experience of lung transplant consultation in a non-transplant centre
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018

Outcomes of telehealth care for lung transplant recipients
Source: Virtual Congress 2021 – Lung graft allocation and monitoring in the 21st century
Year: 2021


Safety and efficacy of outpatient bronchoscopy in lung transplant recipients: A single centre retrospective analysis
Source: Annual Congress 2011 - The basic and the future: pure diagnostic or dedicated wavelengths play
Year: 2011

Evaluation of the biological effects of atorvastatin in lung transplant recipients
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007


Feasibility of smartphone-based physical activity tele-coaching in lung transplant recipients
Source: Virtual Congress 2021 – Digital health interventions in respiratory medicine
Year: 2021


Estimation of quality of life (QoL) of lung transplant recipients by members of the transplant team in comparison with the patients‘ perception
Source: Eur Respir J 2006; 28: Suppl. 50, 723s
Year: 2006

Specificities of the paediatric lung transplant recipient
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005


CMV management in lung transplant recipients
Source: School Course 2012 - Lung Transplantation
Year: 2012


Impact of donor, recipient and matching on survival after high emergency lung transplantation in France
Source: Eur Respir J, 54 (5) 1900096; 10.1183/13993003.00096-2019
Year: 2019



Covid 19 in a lung transplant population
Source: Virtual Congress 2021 – Challenging problems in lung transplantation
Year: 2021


SARS-CoV-2 infection in transplant recipients: experience of a COVID-19 unit in Portugal
Source: Virtual Congress 2021 – COVID - 19 around the globe
Year: 2021


Exercise training for lung transplant candidates and recipients: a systematic review
Source: Eur Respir Rev, 29 (158) 200053; 10.1183/16000617.0053-2020
Year: 2020



Indication, patient selection and timing of referral for lung transplantation
Source: Eur Respir Mon; 2009: 45: 1–5
Year: 2009

Lung transplant outcomes in bronchiectasis –a single center experience
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019